Literature DB >> 14523457

GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia.

J Jazbec, R Aplenc, V Dolzan, M Debeljak, B Jereb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14523457     DOI： 10.1038/sj.leu.2403164

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia.

Authors:  Nina Erčulj; Barbara Faganel Kotnik; Maruša Debeljak; Janez Jazbec; Vita Dolžan
Journal:  J Cancer Res Clin Oncol       Date:  2012-07-01       Impact factor: 4.553

2.  Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.

Authors:  Kjeld Schmiegelow; Ibrahim Al-Modhwahi; Mette Klarskov Andersen; Mikael Behrendtz; Erik Forestier; Henrik Hasle; Mats Heyman; Jon Kristinsson; Jacob Nersting; Randi Nygaard; Anne Louise Svendsen; Kim Vettenranta; Richard Weinshilboum
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

3.  Glutathione s-transferases in pediatric cancer.

Authors:  Wen Luo; Michelle Kinsey; Joshua D Schiffman; Stephen L Lessnick
Journal:  Front Oncol       Date:  2011-10-24       Impact factor: 6.244

4.  Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers.

Authors:  Rohit P Ojha; Joseph E Tota; Tabatha N Offutt-Powell; James L Klosky; Timothy D Minniear; Bradford E Jackson; James G Gurney
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

5.  Antioxidant defence-related genetic variants are not associated with higher risk of secondary thyroid cancer after treatment of malignancy in childhood or adolescence.

Authors:  Ana Lina Vodusek; Katja Goricar; Barbara Gazic; Vita Dolzan; Janez Jazbec
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

6.  Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinoma.

Authors:  Blaz Krhin; Katja Goricar; Barbara Gazic; Vita Dolzan; Nikola Besic
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.